Protective effects and mechanisms of tetramethypyrazine on accelerated anti-GBM antibody nephritis in rats

Chinese Pharmacological Bulletin

Volumn 20, Issue 2, 2004, Pages 196-199

  Fu, Hong ^a   Li, Qi Xiong ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Anti GBM antibody nephritis; Protective effects; Tetramethypyrazine

Indexed keywords

CATALASE; CREATININE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; PROTEIN; SUPEROXIDE DISMUTASE; TETRAMETHYLPYRAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVITY; KIDNEY CORTEX; LIPID PEROXIDATION; MALE; MITOCHONDRION; NEPHRITIS; NONHUMAN; OXIDATION; PROTEIN URINE LEVEL; RAT; UREA NITROGEN BLOOD LEVEL;

EID: 1942537036     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Laurent B. Reactive oxygen species: Production and in the kidney. Am J Physiol, 1986; 251: 765-9
2. Lowen Stein J, Schacht RG, Baldwin DS. Renal failure in minimal change nephritic syndrome. Am J Med, 1981; 70(2): 227-32
3. Krakower CS, Greenspon SA. Localization of nephrotoxic antigen within the isolated renal glomerulus. Arch Path, 1951; 51: 529-33
4. Lan HY, Nikolic-Paterson DJ, Zarama M et al. Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. Kidney Int, 1993; 43(2): 479-85
5. Fang YZ, Zheng JL, Liu ZF et al. Observations of blood glutathione peroxidase, superoxide dismutase and catalase activities in several hematopathy patients. Chin J Hematol, 1986; 7(4): 220-3
6. Noji T, Sato H, Sano J et al. Treatment with an adenosine uptake inhibitor attenuates glomerulonephritis in mice. Eur J Pharmacol, 2002; 449(3): 293-300
7. Devasena T, Lalitha S, Padma K. Lipid peroxidation, osmotic fragility and antioxidant status in children with acute post-streptococcal glomerulonephritis. Clini Chim Acta, 200 1; 308 (1-2): 155-62